Godavari Drugs

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: INE362C01012
NSEID:
BSEID: 530317
View on BSE

INR

102.50

-0.5 (-0.49%)

BSENSE

Aug 11, 03:30 PM

BSE+NSE Vol: 2.17 k

Access older stock analysis version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Smruthi Organic

Makers Labs.

Lactose (India)

Concord Drugs

Godavari Drugs

Tyche Industries

Mercury Labs

Vaishali Pharma

Sotac Pharma.

Pharmaids Pharma

Krebs Biochem

Why is Godavari Drugs Ltd ?

Weak Long Term Fundamental Strength with a -1.78% CAGR growth in Operating Profits over the last 5 years

Low ability to service debt as the company has a high Debt to EBITDA ratio of 7.43 times

Flat results in Mar 26

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Godavari Drugs for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Godavari Drugs

18.52%

0.35

53.27%

Sensex

-3.04%

-0.22

13.54%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-2.92%

EBIT Growth (5y)

-1.78%

EBIT to Interest (avg)

2.33

Debt to EBITDA (avg)

3.93

Net Debt to Equity (avg)

0.88

Sales to Capital Employed (avg)

1.96

Tax Ratio

19.17%

Dividend Payout Ratio

Pledged Shares

0.21%

Institutional Holding

2.74%

ROCE (avg)

12.90%

ROE (avg)

11.67%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.44

EV to EBIT

20.75

EV to EBITDA

15.87

EV to Capital Employed

1.23

EV to Sales

1.54

PEG Ratio

Dividend Yield

ROCE (Latest)

5.94%

ROE (Latest)

5.42%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

Bullish

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company

NET SALES(Q)

At Rs 33.16 cr has Grown at 35.2% (vs previous 4Q average

PBT LESS OI(Q)

Highest at Rs 1.38 cr.

PAT(Q)

Highest at Rs 1.21 cr.

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Godavari Drugs

Net Sales - Quarterly

Highest at Rs 33.16 cr

in the last five quarters

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Net Sales - Quarterly

At Rs 33.16 cr has Grown at 35.2% (vs previous 4Q average)

over average Net Sales of the previous four quarters of Rs 24.54 Cr

MOJO Watch

Near term sales trend is positive

Net Sales (Rs Cr)

Profit Before Tax less Other Income (PBT) - Quarterly

Highest at Rs 1.38 cr.

in the last five quarters

MOJO Watch

Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly

Highest at Rs 1.21 cr.

in the last five quarters

MOJO Watch

Near term PAT trend is positive

PAT (Rs Cr)